Chamberlain, P., Peixoto-de-Matos, S. C., Logan, N. S., Ngo, C., Jones, D., & Young, G. (2019). A 3-year randomized clinical trial of MiSight lenses for Myopia Control. Optometry and Vision Science, 96(8), 556–567. https://doi.org/10.1097/opx.0000000000001410 

 

Fredrick, D. R. (2002). Myopia. BMJ, 324(7347), 1195–1199. https://doi.org/10.1136/bmj.324.7347.1195 

Grzybowski, A., Kanclerz, P., Tsubota, K., Lanca, C., & Saw, S.-M. (2020). A review on the epidemiology of myopia in school children worldwide. BMC Ophthalmology, 20(1). https://doi.org/10.1186/s12886-019-1220-0 

​

Lipson, M. J. (2022). The role of Orthokeratology in Myopia Management. Eye & Contact Lens: Science & Clinical Practice, 48(5), 189–193. https://doi.org/10.1097/icl.0000000000000890 

​

Lyu, Y., Ji, N., Fu, A.-C., Wang, W.-Q., Wei, L., Qin, J., & Zhao, B.-X. (2020). Comparison of administration of 0.02% atropine and orthokeratology for Myopia Control. Eye & Contact Lens: Science & Clinical Practice, 47(2), 81–85. https://doi.org/10.1097/icl.0000000000000699 

​

Walline, J. J. (2016). Myopia Control: A Review. Eye & Contact Lens: Science & Clinical Practice. https://doi.org/10.1097/ICL.0000000000000207 

​

Zhao, C., Cai, C., Ding, Q., & Dai, H. (2020). Efficacy and safety of atropine to control myopia progression: A systematic review and meta-analysis. BMC Opthalmology. https://doi.org/10.21203/rs.3.rs-21025/v3 

​